id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1979-N-0307-0012,FDA,FDA-1979-N-0307,Memorandum from FDA to DDM dated March 4 1980,Other,Memorandum,2014-06-18T04:00:00Z,2014,6,2014-06-18T04:00:00Z,,2014-06-18T16:51:57Z,,0,0,09000064816ede4c
FDA-1979-N-0307-0010,FDA,FDA-1979-N-0307,Letter from FDA to American Cyanamid Company Dated Jan 11 1977,Supporting & Related Material,Background Material,2014-06-18T04:00:00Z,2014,6,,,2014-06-18T16:46:13Z,,0,0,09000064816ede4a
FDA-1979-N-0307-0009,FDA,FDA-1979-N-0307,May et al Optimization of Parameters in Protein Nitrogen Unit Precipitation Procedure for Allergenic Extracts,Supporting & Related Material,Background Material,2014-06-18T04:00:00Z,2014,6,,,2014-06-18T16:43:09Z,,0,0,09000064816edd6d
FDA-1979-N-0307-0013,FDA,FDA-1979-N-0307,Memorandum from FDA to DDM dated October 15 1981,Other,Memorandum,2014-06-18T04:00:00Z,2014,6,2014-06-18T04:00:00Z,,2014-06-18T16:53:05Z,,0,0,09000064816ede4d
FDA-1979-N-0307-0011,FDA,FDA-1979-N-0307,Memorandum and Summary of Data Dated Oct 14 1980,Supporting & Related Material,Background Material,2014-06-18T04:00:00Z,2014,6,,,2014-06-18T16:49:27Z,,0,0,09000064816ede4b